期刊文献+

携紫杉醇和Herceptin高分子造影剂联合超声体外寻靶及显影效果研究 被引量:4

Targeting and imaging study of paclitaxel-loaded and Herceptin-targeted ultrasound contrast agentwith ultrasound in vitro
原文传递
导出
摘要 目的探讨携紫杉醇(Pac)和注射用曲妥珠单克隆抗体(Herceptin)高分子造影剂(Pac.PLGA—HER)联合超声体外寻靶能力及显影效果。方法通过双乳化法和碳二亚胺法制备载Pac靶向高分子造影剂。将MCF-7细胞种植于12个培养皿中,培养24h,分为4组,每组3个:非靶向造影剂组(Pac—PLGA组)、靶向造影剂组(Pac—PLGA—HER组)、靶向造影剂+超声组(Pac—PLGA—HER+超声组)和抗体封闭组。在激光共聚焦显微镜下对比观察高分子造影剂与细胞的结合能力。观察体外显影效果,并用DFY型定量仪进行定量,采用独立样本t检验进行统计学分析。结果靶向载Pac高分子造影剂平均粒径为(596±12)nm,体外寻靶能力实验显示靶向载Pac高分子造影剂可与MCF-7细胞大量结合。体外显影实验示靶向与非靶向载Pac高分子造影剂平均声强分别为(134.50±10.19)和(135.11±11.49)dB,平均灰阶分别为147.83±11.12和148.50±12.63,两者比较差异均无统计学意义(t均为一0.097,P均〉0.05)。结论携Pac和Herceptin的高分子造影剂对高表达HER2的人乳腺癌MCF-7有较强的结合能力,在体外显影实验中有较好的显影效果。 Objective To further explore the affinity of paclitaxel-loaded and trastuzumab (Her- ceptin)-targeted poly( lactic-co-glycolic acid, PLGA)-COOH ultrasound contrast agent (Pac-PLGA-HER) for human breast cancer cell line MCF-7 and study their effect on ultrasound imaging in vitro. Methods Paclitaxel-loaded PLGA-COOH ultrasound contrast agents (Pac-PLGA) were prepared by the double emul- sion technique and conjugated with Herceptin monoclonal antibody by 1-(3-dimethylaminopropyl)-3-ethyl- carbodiimide hydrochloride (EDC)/N-hyalroxysuccinimide (NHS). MCF-7 cells were plated in culture di- shes for 24 h and divided into 4 groups with 3 dishes in each group, i.e. Pac-PLGA group, Pae-PLGA- HER group, ultrasound + Pac-PLGA-HER group and antibody blocking group. Binding of polymer ultra- sound contrast agents to MCF-7 cells was observed by laser scanning eonfocal microscopy. In vitro experi- ments were employed to study the effects of Pac-PLGA-HER on the enhancement of ultrasound imaging as compared with Pac-PLGA, the control group. Independent samples t-test was used for statistical analysis with the help of DFY. Results The average diameter of Pac-PLGA-HER was (596 -+ 12) nm. In the in vitro targeting study, a number of Pac-PLGA-HER bound with MCF-7 cells tightly; while, no conjugation was ob- served in the control group. During in vitro ultrasound imaging, the average sound intensity of Pac-PLGA- HER and Pac-PLGA was ( 134.50 ~ 10. 19) and ( 135.11 + 11.49) dB ( t = - 0. 097, P 〉 0.05) and the average grey scale was 147.83 + 11.12 and 148.50 ~ 12.63 ( t = - 0. 097, P 〉 0.05 ), respectively. There was no difference between the two. Conclusion Pac-PLGA-HER could bind to high HER2-expressingMCF-7 cells specifically and effectively and was an effective ultrasound contrast agent in vitro.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2012年第2期100-104,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 国家自然科学基金(30970752,30770566,81130025) 重庆高校优秀成果转化资助项目(Kjzhl0201)
关键词 造影剂 紫杉醇 HERCEPTIN 超声检查 细胞学 乳腺肿瘤 Contrast media Paclitaxel Herceptin Uhrasonography Cytology Breast neoplasms
  • 相关文献

参考文献15

  • 1Moasser MM. Targeting the function of the HER2 oncogene in human caner therapeutics[J].Oncogene,2007.6577-6592.
  • 2Martins SJ,Yamamoto CA. Clinical and economic issues in adjuvant chemotherapy for HER-2 positive breast cancer[J].Revista da Associacao Medica Brasileira,2008.494-499.
  • 3Chia S,Norris B,Speers C. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers[J].Journal of Clinical Oncology,2008.5697-5704.
  • 4Milanezi F,Carvalho S,Schmitt FC. EGFR/HER2 in breast cancer:a biological approach for molecular diagnosis and therapy[J].Expert Review of Molecular Diagnostics,2008.417-434.
  • 5冉海涛,任红,王志刚,郑元义,张群霞,李小东,许川山.包裹阿霉素的高分子材料微泡声学造影剂制备及显影效果实验研究[J].临床超声医学杂志,2005,7(4):217-220. 被引量:50
  • 6骆杰,王志刚,张群霞,钟世根,张辉,郑元义.携Herceptin靶向高分子造影剂的制备及体外寻靶能力研究[J].中华超声影像学杂志,2010,19(8):723-726. 被引量:4
  • 7Cheng J,Teply BA,Sheriff I. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery[J].Biomaterials,2007.869-876.
  • 8Danhier F,Lecouturier N,Vroman B. Paclitaxel-loaded PEG-ylated PLGA-based nanoparticles:in vitro and in vivo evaluation[J].Journal of Controlled Release,2009,(1):11-17.doi:10.1016/j.jconrel.2008.09.086.
  • 9Garinot M,Fievez V,Pourcelle V. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination[J].Journal of Controlled Release,2007,(3):195-204.doi:10.1016/j.jconrel.2007.04.021.
  • 10Danhier F,Vroman B,Lecouturier N. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel[J].Journal of Controlled Release,2009.166-173.

二级参考文献19

  • 1冉海涛,任红,王志刚,郑元义,张群霞,李小东,许川山.包裹阿霉素的高分子材料微泡声学造影剂制备及显影效果实验研究[J].临床超声医学杂志,2005,7(4):217-220. 被引量:50
  • 2冉海涛,任红,王志刚,郑元义,张群霞,许川山.自制高分子聚合材料超声造影剂显影效果动物实验研究[J].中华超声影像学杂志,2006,15(5):378-380. 被引量:11
  • 3Fang Nie,Hui-Xiong Xu,Qing Tang,Ming-De Lu.Microbubble-enhanced ultrasound exposure improves gene transfer in vascular endothelial cells[J].World Journal of Gastroenterology,2006,12(46):7508-7513. 被引量:21
  • 4Chia S,Norris B,Speers C,et al.Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.J Clin Oncol,2008,10:5697-5704.
  • 5Martins SJ,Yamamoto CA.Clinical and economic issues in adjuvant chemotherapy for HER-2 positive breast cancer.Rev Assoc Med Bras,2008,54:494-499.
  • 6Wesolowski R,Budd GT.Neoadjuvant therapy for breast cancer;assessing treatment progress and managing poor responders.Curr Oncol Rep,2009,11:37-44.
  • 7Marty M,Cognetti F,Maraninchi D,et al.Randomized phase Ⅱ trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as firstline treatment:the M77001 study group.J Clin Oncol,2005,23:4265-4274.
  • 8Kocbek P,Obermajer N,Cegnar M,et al..Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.J Control Release,2007,120:18-26.
  • 9Zhang Q,Wang Z,Ran H,et al.Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques.Acad Radiol,2006,13:363-367.
  • 10Linker RA,Reinhardt M,Bendszus M,et al.In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE).J Autoimmun,2005,25:199-205.

共引文献56

同被引文献37

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部